Cure Defense Fund
Cure Defense Fund maintains stable assets with no reported officer compensation despite fluctuating revenues.
EIN: 203928822 · Royal Oak, MI · NTEE: S41 · Updated: 2026-03-28
About Cure Defense Fund
Cure Defense Fund (EIN: 203928822) is a nonprofit organization based in Royal Oak, MI, classified under NTEE code S41. The organization reported total revenue of $1.4M and total assets of $4.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cure Defense Fund's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Cure Defense Fund with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, Cure Defense Fund allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Executive Compensation Analysis
Cure Defense Fund consistently reports 0% officer compensation across all 14 available filings, indicating that its leadership is either entirely volunteer-based or compensated through non-officer roles, which is highly unusual for an organization of its size and revenue.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Cure Defense Fund's IRS 990 filings:
- Significant revenue fluctuations over the past decade, from over $5.7M in 2015 to $1.9M in 2023, could indicate inconsistent funding or donor reliance.
- Lack of detailed functional expense breakdown (program, admin, fundraising) in the provided summary makes it difficult to fully assess spending efficiency.
Strengths
The following positive indicators were identified for Cure Defense Fund:
- Consistent reporting of 0% officer compensation across all 14 filings, indicating a strong commitment to minimizing executive overhead.
- Healthy asset-to-liability ratio, with assets of $4,677,055 significantly exceeding liabilities of $96,012 in 2023, demonstrating strong financial health.
- Positive net income in recent years (e.g., 2023 revenue $1,939,616 vs. expenses $1,795,632), contributing to asset growth.
Frequently Asked Questions about Cure Defense Fund
Is Cure Defense Fund a good charity?
Based on the available data, Cure Defense Fund appears to be a financially stable organization with a strong commitment to minimizing executive compensation. Its consistent reporting of 0% officer compensation is a significant positive indicator for donors concerned about overhead. However, a full assessment of 'goodness' would benefit from detailed program spending ratios.
How has Cure Defense Fund's revenue trended over time?
Cure Defense Fund's revenue has shown significant fluctuation, peaking at $5,764,387 in 2015 and $5,432,309 in 2016, then generally declining to $1,939,616 in 2023. This indicates a need for consistent fundraising efforts or a shift in funding sources.
What is the organization's financial stability?
The organization demonstrates good financial stability. Its assets have consistently exceeded liabilities, with $4,677,055 in assets against $96,012 in liabilities in 2023, and a healthy asset base maintained over the past decade, indicating a strong balance sheet.
Filing History
IRS 990 filing history for Cure Defense Fund showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2008–2023), Cure Defense Fund's revenue has grown by 4795.2%, moving from $40K to $1.9M. Total assets increased by 3137.3% over the same period, from $144K to $4.7M. Total functional expenses rose by 1124.2%, from $147K to $1.8M. In its most recent filing year (2023), Cure Defense Fund reported a surplus of $144K, with revenue exceeding expenses. The organization holds $96K in liabilities against $4.7M in assets (debt-to-asset ratio: 2.1%), resulting in net assets of $4.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $1.9M | $1.8M | $4.7M | $96K | — | — |
| 2022 | $2.2M | $1.5M | $5.7M | $1.2M | — | View 990 |
| 2021 | $2.2M | $1.6M | $4.8M | $1.3M | — | View 990 |
| 2020 | $1.8M | $2.8M | $4.2M | $1.3M | — | View 990 |
| 2019 | $3.7M | $3.8M | $5.5M | $1.6M | — | — |
| 2018 | $3.7M | $3.0M | $4.7M | $689K | — | View 990 |
| 2017 | $3.7M | $4.3M | $4.3M | $969K | — | View 990 |
| 2016 | $5.4M | $4.0M | $4.5M | $719K | — | View 990 |
| 2015 | $5.8M | $3.7M | $2.6M | $417K | — | View 990 |
| 2014 | $4.1M | $5.1M | $314K | $204K | — | View 990 |
| 2013 | $1.9M | $1.3M | $1.2M | $31K | — | View 990 |
| 2012 | $2.5M | $2.3M | $599K | $36K | — | View 990 |
| 2011 | $412K | $86K | $401K | $33K | — | View 990 |
| 2008 | $40K | $147K | $144K | $2K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.9M, expenses of $1.8M, and assets of $4.7M (revenue -11.8% year-over-year).
- 2022: Revenue of $2.2M, expenses of $1.5M, and assets of $5.7M (revenue +0.9% year-over-year).
- 2021: Revenue of $2.2M, expenses of $1.6M, and assets of $4.8M (revenue +22.3% year-over-year).
- 2020: Revenue of $1.8M, expenses of $2.8M, and assets of $4.2M (revenue -51.8% year-over-year).
- 2019: Revenue of $3.7M, expenses of $3.8M, and assets of $5.5M (revenue +1.2% year-over-year).
- 2018: Revenue of $3.7M, expenses of $3.0M, and assets of $4.7M (revenue -2.4% year-over-year).
- 2017: Revenue of $3.7M, expenses of $4.3M, and assets of $4.3M (revenue -31.0% year-over-year).
- 2016: Revenue of $5.4M, expenses of $4.0M, and assets of $4.5M (revenue -5.8% year-over-year).
- 2015: Revenue of $5.8M, expenses of $3.7M, and assets of $2.6M (revenue +40.4% year-over-year).
- 2014: Revenue of $4.1M, expenses of $5.1M, and assets of $314K (revenue +120.5% year-over-year).
- 2013: Revenue of $1.9M, expenses of $1.3M, and assets of $1.2M (revenue -26.5% year-over-year).
- 2012: Revenue of $2.5M, expenses of $2.3M, and assets of $599K (revenue +515.3% year-over-year).
- 2011: Revenue of $412K, expenses of $86K, and assets of $401K (revenue +938.8% year-over-year).
- 2008: Revenue of $40K, expenses of $147K, and assets of $144K.
Data Sources and Methodology
This transparency report for Cure Defense Fund is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.